Objectives: The prevalence of opioid use disorder (OUD) during pregnancy is increasing.
Practical recommendations will help providers treat pregnant women with OUD and reduce …

Substance use during pregnancy is at least as common as many of the medical conditions
screened for and managed during pregnancy. While harmful and costly, it is often ignored or …

In April 2016, the Eunice Kennedy Shriver National Institute of Child Health and Human
Development invited experts to a workshop to address numerous knowledge gaps and to …

Opioid abuse among pregnant women has reached epidemic proportions and has
influenced maternal and child health policy at the federal, state, and local levels. As a result …

Objectives Substance misuse during pregnancy can be harmful to the health of both mothers
and infants. Existing recovery services or prenatal care for pregnant women with substance …

OBJECTIVE: To evaluate temporal trends in medication-assisted treatment use among
pregnant women with opioid use disorder. METHODS: We conducted a retrospective cohort …

Pregnancy is an opportune time to identify opioid dependence, facilitate conversion to
opioid maintenance treatment, and coordinate care with specialists in addiction medicine …

Women who use substances in pregnancy are an underserved population with a higher risk
for maternal morbidity and neonatal morbidity and mortality. Maternal substance use affects …

Pregnant women with opioid use disorder can be treated with methadone, buprenorphine,
or naltrexone to reduce opioid use and improve retention to treatment. In this review, we …

Problem addressed Infants born to opioid-dependent women are admitted to intensive care
units for management of neonatal abstinence syndrome (NAS), serious morbidity, and …